» Articles » PMID: 15953348

Differential Monoaminergic, Neuroendocrine and Behavioural Responses After Central Administration of Corticotropin-releasing Factor Receptor Type 1 and Type 2 Agonists

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2005 Jun 15
PMID 15953348
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Corticotropin-releasing factor (CRF) mediates various aspects of the stress response. To differentiate between the roles of CRF(1) and CRF(2) receptor subtypes in monoaminergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity and behaviour we compared the effects of CRF and urocortin 1 with those of the selective CRF(2) receptor ligands urocortin 2 and urocortin 3. In vivo microdialysis in the rat hippocampus was used to assess free corticosterone, extracellular levels of serotonin (5-HT) and noradrenaline (NA), and their metabolites 5-hydroxyindoleacetic acid (5-HIAA) and 3-methoxy-4-hydroxyphenylglycol (MHPG), respectively. Intracerebroventricular (i.c.v.) injection of CRF and urocortin 1, 2 and 3 (1.0 microg) increased hippocampal levels of 5-HT and 5-HIAA. CRF and urocortin 1 increased NA and MHPG, whereas urocortin 2 and urocortin 3 elevated MHPG, but not NA levels. CRF and the urocortins induced an immediate increase in behavioural activity. CRF and urocortin 1 mainly caused grooming and exploratory behaviour. In contrast, urocortin 2 and urocortin 3 both induced exploratory behaviour, but not grooming, and increased time spent eating food pellets. All urocortins, but not CRF, suppressed food intake 4-6 h after injection. Hippocampal free corticosterone levels were elevated by CRF, urocortin 1 and 3, but not by urocortin 2. The time courses of the CRF- and urocortin 1-induced responses were significantly prolonged as compared to those of the CRF(2) receptor ligands. The stimulatory changes evoked by CRF and urocortin 1 were present up to 4-6 h after injection, whereas the effects of urocortin 2 and urocortin 3 returned to baseline within 2.5 h after injection. Pre-treatment with the selective antagonist antisauvagine-30 (5.0 microg, i.c.v.) confirmed that the effects of urocortin 3 were CRF(2) receptor-mediated. The differential time course of the monoaminergic, neuroendocrine and behavioural effects of CRF and urocortin 1, as compared to urocortin 2 and urocortin 3, and the specific behavioural pattern induced by the CRF(2) receptor ligands, suggest a distinct role for CRF(2) receptors in the stress response.

Citing Articles

Anxiety and Depression: What Do We Know of Neuropeptides?.

Kupcova I, Danisovic L, Grgac I, Harsanyi S Behav Sci (Basel). 2022; 12(8).

PMID: 36004833 PMC: 9405013. DOI: 10.3390/bs12080262.


Molecular characterization of melanin-concentrating hormone (MCH) in Schizothorax prenanti: cloning, tissue distribution and role in food intake regulation.

Wang T, Yuan D, Zhou C, Lin F, Wei R, Chen H Fish Physiol Biochem. 2015; 42(3):883-93.

PMID: 26690629 DOI: 10.1007/s10695-015-0182-2.


Chronic and acute effects of stress on energy balance: are there appropriate animal models?.

Harris R Am J Physiol Regul Integr Comp Physiol. 2014; 308(4):R250-65.

PMID: 25519732 PMC: 4329465. DOI: 10.1152/ajpregu.00361.2014.


Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior.

Fox J, Lowry C Front Neurosci. 2013; 7:169.

PMID: 24065880 PMC: 3778254. DOI: 10.3389/fnins.2013.00169.


Cannabinoid CB1 receptors mediate the effects of corticotropin-releasing factor on the reinstatement of cocaine seeking and expression of cocaine-induced behavioural sensitization.

Kupferschmidt D, Klas P, Erb S Br J Pharmacol. 2012; 167(1):196-206.

PMID: 22489809 PMC: 3448923. DOI: 10.1111/j.1476-5381.2012.01983.x.